These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 229592)

  • 21. Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation.
    Lijfering WM; de Vries AP; Veeger NJ; van Son WJ; Bakker SJ; van der Meer J
    Thromb Haemost; 2008 Jan; 99(1):127-32. PubMed ID: 18217144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transplanted kidney as a source of cytomegalovirus infection.
    Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA
    N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
    Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
    Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection and kidney graft survival.
    Spencer ES; Fjeldborg O; Andersen HK
    Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH; Mao YY; He Q; Wu JY; Lv R
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor age and outcome of liver transplantation.
    Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
    Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary and secondary cytomegalovirus infection.
    Suwansirikul S; Rao N; Dowling JN; Ho M
    Arch Intern Med; 1977 Aug; 137(8):1026-9. PubMed ID: 195547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection and graft survival in renal graft recipients.
    Cappel R; Hestermans O; Toussaint C; Vereerstraeten P; van Beers D; de Braekeleer J; Schoutens E
    Arch Virol; 1978; 56(1-2):149-56. PubMed ID: 204269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients.
    Chatterjee SN; Fiala M; Weiner J; Stewart JA; Stacey B; Warmer N
    JAMA; 1978 Nov; 240(22):2446-9. PubMed ID: 213620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of cytomegalovirus and herpes simplex virus disease in renal transplant recipients.
    Walker DP; Longson M; Mallick NP; Johnson RW
    J Clin Pathol; 1982 Nov; 35(11):1190-3. PubMed ID: 6292261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of renal transplantation in patients with primary cytomegalovirus infection.
    Pass RF; Whitley RJ; Diethelm AG; Whelchel JD; Reynolds DW; Alford CA
    Transplant Proc; 1979 Jun; 11(2):1288-90. PubMed ID: 224539
    [No Abstract]   [Full Text] [Related]  

  • 37. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.
    Grundy JE; Lui SF; Super M; Berry NJ; Sweny P; Fernando ON; Moorhead J; Griffiths PD
    Lancet; 1988 Jul; 2(8603):132-5. PubMed ID: 2899189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Holoendemic cytomegalovirus infection in renal transplant recipients.
    Fiala M; Chatterjee SN; Payne JE; Stacey B; Cosgrove D; Berne TV
    Yale J Biol Med; 1976 Mar; 49(1):67. PubMed ID: 183385
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved cadaver allograft survival in transfused recipients who remain serologically negative for cytomegalovirus.
    Flechner SM; Novick AC; Steinmuller D
    J Urol; 1982 Apr; 127(4):644-7. PubMed ID: 6279886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus excretion 2-14 years after renal transplantation.
    Cheeseman SH; Stewart JA; Winkle S; Cosimi AB; Tolkoff-Rubin NE; Russell PS; Baker GP; Herrin J; Rubin RH
    Transplant Proc; 1979 Mar; 11(1):71-4. PubMed ID: 222020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.